United States
US 12,702,659 B2
Rifaximin liquid formulations
US 12,702,659 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Bausch Health Ireland Limited. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Bausch Health Ireland Limited
- Inventors
- Arturo J. Angel; Kasturi R. Pawar; Radhakrishnan S. Pillai
- Publication date
- 2026-08-11
- Filing date
- 2022-03-24
- Document type
- B2 Granted patent
- Also written as
- US 12,702,659 B2 · US12702659 · 12702659
Abstract
Provided herein are pharmaceutical compositions which enhance the intestinal levels of soluble rifaximin, formulations comprising said compositions, and their use in treating one or more bowel related disorders.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free